ReviewFrontiers in drug safety and regulation2025
Centralized daily drug management in clinical trial institutions and specific implementation plans.
Review in Frontiers in drug safety and regulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Experimental drug management is an important part of clinical trial management and directly relates to the reliability of clinical trial data and the safety of participants. This study explores the implementation of centralized pharmacy management in clinical drug trials, addressing the limitations of decentralized approaches. Methods: It involves the establishment of a centralized drug warehouse with unified processes and digital systems, primarily relying on the Cold Chain Cloud Platform, Service Cloud Platform, and Enterprise WeChat Platform, to enhance precision and efficiency. Results: It indicated a significant reduction in error rates and improved adherence to clinical trial protocols. The centralized model also minimized protocol deviations and strengthened participant safety. Conclusion: It highlights the benefits of centralized management in enhancing drug administration efficiency and maintaining high standards of trial conduct, suggesting future integration with Artificial Intelligence (AI) and Electronic Health Records (EHR) for more precise pharmaceutical services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.